BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

LEUKOCARE Has Been Granted Both ISO 9001 And ISO 13485 Certification


2/24/2010 2:14:13 PM

LEUKOCARE AG, a privately-owned company developing innovative biofunctional surfaces using its proprietary stabilizing postcoating technology, today announced that it has successfully established a Quality Management System (QMS) in accordance with ISO 9001:2008 and ISO 13485:2003 standards for medical devices.

In order to achieve ISO standards, LEUKOCARE implemented a QMS for its operations to ensure consistent and high quality of the company’s development processes. KEMA Quality B.V. audited LEUKOCARE for the design, development, manufacturing and distribution of technologies and products for biofunctional surface engineering and stabilisation of biomolecules in the field of medical devices, diagnostics, research products and biopharmaceuticals.

“By achieving ISO certification, LEUKOCARE can now offer full quality assurance in terms of development and implementation of our postcoating technology”, stated Michael Scholl, CEO of LEUKOCARE. “We are developing our technology for additional product ranges and this requires us to operate only on the highest standards of international quality.”

About LEUKOCARE

LEUKOCARE is a leading solution provider of biofunctional surfaces for medical devices and stabilized proteins resistant to standard sterilization processes. As a product-focused, clinical-stage biotechnology company, LEUKOCARE uses its proprietary stabilizing postcoating technology to couple, protect and elute biofunctional molecules. LEUKOCARE can functionalize a wide variety of surfaces including orthopedic implants, wound dressings, patches, stents, catheters, columns for ex-vivo blood treatment and others. LEUKOCARE leverages its comprehensive biofunctional coating expertise in product-focused industry partnerships. The company also offers its know-how in biofunctional coatings and product development to interested parties on a flexible basis, ranging from service-based collaborations to co-development partnerships. LEUKOCARE is a privately-owned biotechnology company founded in 2001 and headquartered in Munich, Germany.

For further information please visit our homepage www.leukocare.com or contact us:


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES